Real world experience of palbociclib in hormone receptor-positive metastatic breast cancer.

被引：3
|
作者：
Malik, Faizan
Ali, Naveed
Jafri, Syed Imran Mustafa
Sundermeyer, Mark L.
Seidman, Michael Jeffrey
Fidler, Christian Joseph
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e18094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18094
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
    Morita, Midori
    Ooe, Asako
    Ishii, Wataru
    Watanabe, Akira
    Matsui, Chise
    Okuyama, Yuka
    Kitano, Sae
    Kato, Chikage
    Onishi, Mie
    Sakaguchi, Koichi
    Naoi, Yasuto
    ANTICANCER RESEARCH, 2023, 43 (06) : 2783 - 2789
  • [22] Palbociclib in advanced hormone receptor positive breast cancer: A real world study in South America
    Sanchez, Cesar
    Samtani, Suraj
    Gomez, Henry
    Falcon-Lizaraso, Silvia
    Munoz, Rene
    Soria, Tannia
    CANCER RESEARCH, 2024, 84 (09)
  • [23] Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer
    Yuan, Yuan
    Lee, Jin Sun
    Yost, Susan E.
    Frankel, Paul H.
    Ruel, Christopher
    Egelston, Colt A.
    Guo, Weihua
    Padam, Simran
    Tang, Aileen
    Martinez, Norma
    Schmolze, Daniel
    Presant, Cary
    Ebrahimi, Behnam
    Yeon, Christina
    Sedrak, Mina
    Patel, Niki
    Portnow, Jana
    Lee, Peter
    Mortimer, Joanne
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 11 - 20
  • [24] Alternative Palbociclib Dosing Schedules for Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer
    Go, Makiko
    Kimura, Michio
    Yamada, Shiori
    Kamei, Keitaro
    Noguchi, Yoshinori
    Usami, Eiseki
    Yoshimura, Tomoaki
    ONCOLOGY, 2024,
  • [25] Efficacy of palbociclib after everolimus in hormone receptor-positive, HER2-negative advanced breast cancer.
    Kovac, Anja
    Kuhar, Cvetka Grasic
    Ovcaricek, Tanja
    Matos, Erika
    Mencinger, Marina
    Borstnar, Simona
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer
    Sg, Nithin
    Gogia, Ajay
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (08)
  • [27] Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment
    Dhakal, Ajay
    Matthews, Christina M.
    Levine, Ellis Glenn
    Salerno, Kilian Elizabeth
    Zhang, Fan
    Takabe, Kazuaki
    Early, Amy P.
    Edge, Stephen B.
    O'Connor, Tracy
    Khoury, Thaer
    Young, Jessica S.
    Opyrcha, Mateusz
    CLINICAL BREAST CANCER, 2018, 18 (06) : E1401 - E1405
  • [28] TISSUE PROTEOME ANALYSIS OF HORMONE RECEPTOR-POSITIVE BREAST CANCER.
    Yoneten, K. Karaosmanoglu
    Gunes, A.
    Kasap, M.
    Utkan, N. Z.
    Akpinar, G.
    Gurel, B.
    Guler, S. A.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [29] Fulvestrant in management of hormone receptor-positive metastatic breast cancer
    Shafaee, Maryam Nemati
    Ellis, Matthew James
    FUTURE ONCOLOGY, 2018, 14 (18) : 1789 - 1800
  • [30] Real world clinical outcomes of palbociclib in hormone receptor positive (HR plus ) metastatic breast cancer (MBC) patients.
    Eziokwu, Akaolisa Samuel
    Varella, Leticia
    Kruse, Megan Lynn
    Jia, Xuefei
    Moore, Halle C. F.
    Budd, George Thomas
    Abraham, Jame
    Montero, Alberto J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345